Irinotecan hydrochloride contains not less than 98.0 percent and not more than 102.0 percent of C33H38N4O6HCl？3H2O calculated on the dried basis.

共有 1 個藥物證書使用此成份

"台灣神隆" 艾諾肯
Irinotecan hydrochloride "SPT"

• 申請商: 台灣神隆股份有限公司
• 適應症: 抗癌藥(Antineoplastic)。
• 含量: 0.000000
• 發證日期: 2006-09-07